slow responder to glp 1 The GLP-1 Troubleshooting Guide: Science-Based Solutions for Semaglutide, Tirzepatide, and Other GLP-1s for Respond, (Paperback) Frontiers | GLP-1 Receptor Agonists:
Description
Although not specifically approved for weight loss, it has shown promising results for this purpose, with many patients experiencing noticeable weight loss
Zepbound administration starts at 2.5 mg for the first 4 weeks, then increases to 5 mg
This is not just innovation, but evolution in obesity care
Liu, Z., Duan, X., & Yuan, M
& Butzner, D
